Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiongbin Lu

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Cellular Signalling|October 31, 2009
USP11 negatively regulates TNFalpha-induced NF-kappaB activation by targeting on IkappaBalphaWenjing Sun, Xiaojie Tan, Yi Shi, et al.
Oncogenesis|January 24, 2018
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and AktRajasekhara Reddy Katreddy, Lakshmi Reddy Bollu, Fei Su, et al.
The Journal of Clinical Investigation|April 13, 2018
Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancerYunhua Liu, Hanchen Xu, Kevin Van der Jeught, et al.
Nature|April 23, 2015
TP53 loss creates therapeutic vulnerability in colorectal cancerYunhua Liu, Xinna Zhang, Cecil Han, et al.
Nature Biomedical Engineering|November 2, 2021
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicityZhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, et al.
Science Advances|September 26, 2025
STK11 coordinates IL-4 signaling with metabolic reprogramming to control M2 macrophage polarization and antitumor immunityJing Yang, Naresh Singh, Chengxian Xu, et al.
Breast Cancer Research : BCR|August 7, 2019
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancersBradley A Hancock, Yu-Hsiang Chen, Jeffrey P Solzak, et al.
Nature Communications|February 26, 2026
Tumor-associated CD19<sup>+</sup> macrophages induce immunosuppressive microenvironment in hepatocellular carcinomaJunli Wang, Wanyue Cao, Jinyan Huang, et al.
Nature Communications|August 22, 2025
Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancerHanshen Yang, Xiaozhen Zhang, Sirui Zhang, et al.
JCI Insight|May 8, 2020
ST2 as checkpoint target for colorectal cancer immunotherapyKevin Van der Jeught, Yifan Sun, Yuanzhang Fang, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Cellular Signalling|October 31, 2009
USP11 negatively regulates TNFalpha-induced NF-kappaB activation by targeting on IkappaBalphaWenjing Sun, Xiaojie Tan, Yi Shi, et al.
Oncogenesis|January 24, 2018
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and AktRajasekhara Reddy Katreddy, Lakshmi Reddy Bollu, Fei Su, et al.
The Journal of Clinical Investigation|April 13, 2018
Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancerYunhua Liu, Hanchen Xu, Kevin Van der Jeught, et al.
Nature|April 23, 2015
TP53 loss creates therapeutic vulnerability in colorectal cancerYunhua Liu, Xinna Zhang, Cecil Han, et al.
Nature Biomedical Engineering|November 2, 2021
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicityZhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, et al.
Science Advances|September 26, 2025
STK11 coordinates IL-4 signaling with metabolic reprogramming to control M2 macrophage polarization and antitumor immunityJing Yang, Naresh Singh, Chengxian Xu, et al.
Breast Cancer Research : BCR|August 7, 2019
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancersBradley A Hancock, Yu-Hsiang Chen, Jeffrey P Solzak, et al.
Nature Communications|February 26, 2026
Tumor-associated CD19<sup>+</sup> macrophages induce immunosuppressive microenvironment in hepatocellular carcinomaJunli Wang, Wanyue Cao, Jinyan Huang, et al.
Nature Communications|August 22, 2025
Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancerHanshen Yang, Xiaozhen Zhang, Sirui Zhang, et al.
JCI Insight|May 8, 2020
ST2 as checkpoint target for colorectal cancer immunotherapyKevin Van der Jeught, Yifan Sun, Yuanzhang Fang, et al.
Pageof 12